Related references
Note: Only part of the references are listed.Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment
Johannes Eimer et al.
CLINICAL INFECTIOUS DISEASES (2023)
Linezolid-related adverse effects in the treatment of rifampicin resistant tuberculosis: a retrospective study
Dan Cui et al.
JOURNAL OF CHEMOTHERAPY (2023)
Linezolid toxicity in patients with drug-resistant tuberculosis: a prospective cohort study
Sean Wasserman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)
Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis
Laurynas Mockeliunas et al.
PHARMACEUTICS (2022)
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis
Bern-Thomas Nyang'wa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Linezolid Exposure Is Associated with Cytopenias in Patients Treated for Multidrug-Resistant Tuberculosis
Daniel S. Graciaa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis
Francesca Conradie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics
Gauri G. Rao et al.
THERAPEUTIC DRUG MONITORING (2020)
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Francesca Conradie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment Analysis
Wael A. Alghamdi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France
Marie Jaspard et al.
EMERGING INFECTIOUS DISEASES (2020)
Treatment of multidrug-resistant tuberculosis using therapeutic drug monitoring: first experiences with sub-300 mg linezolid dosages using in-house made capsules
Mathieu S. Bolhuis et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study
Pier Giorgio Cojutti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation
James Millard et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Linezolid-based Regimens for Multidrug-resistant Tuberculosis (TB): A Systematic Review to Establish or Revise the Current Recommended Dose for TB Treatment
Mathieu S. Bolhuis et al.
CLINICAL INFECTIOUS DISEASES (2018)
Model-Informed Precision Dosing at the Bedside: Scientific Challenges and Opportunities
Ron J. Keizer et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2018)
Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients
Yasuhiro Tsuji et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis
Shashikant Srivastava et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps
Devyani Deshpande et al.
CLINICAL INFECTIOUS DISEASES (2016)
Therapeutic drug management of linezolid: a missed opportunity for clinicians?
Dario Cattaneo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Edoxaban Exposure-Response Analysis and Clinical Utility Index Assessment in Patients With Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
J. Nyberg et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis
Taeksun Song et al.
EBIOMEDICINE (2015)
Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid
Lauren M. Boak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients
Kazuaki Matsumoto et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia
Yoko Nukui et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and Xpose
R. J. Keizer et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients
Federico Pea et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Population Pharmacokinetic and Pharmacodynamic Analysis of Linezolid and a Hematologic Side Effect, Thrombocytopenia, in Japanese Patients
Tomohiro Sasaki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Linezolid-related immune-mediated severe thrombocytopenia
Dulce Pascoalinho et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis
Federico Pea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Benefit-risk assessment: the use of clinical utility index
Daniele Ouellet
EXPERT OPINION ON DRUG SAFETY (2010)
Modeling Subpopulations with the $MIXTURE Subroutine in NONMEM: Finding the Individual Probability of Belonging to a Subpopulation for the Use in Model Analysis and Improved Decision Making
Kristin C. Carlsson et al.
AAPS JOURNAL (2009)
MMRM vs. LOCF: A Comprehensive Comparison Based on Simulation Study and 25 NDA Datasets
Ohidul Siddiqui et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2009)
Survival analysis: up from Kaplan-Meier-Greenwood
Olli S. Miettinen
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2008)
The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria
Karen L. Leach et al.
MOLECULAR CELL (2007)
Linezolid-induced inhibition of mitochondrial protein synthesis
AS De Vriese et al.
CLINICAL INFECTIOUS DISEASES (2006)
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
A Trotti et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
Mechanisms for linezolid-induced anemia and thrombocytopenia
WB Bernstein et al.
ANNALS OF PHARMACOTHERAPY (2003)
Share Paper
